Skip to content

Free cash flow at other companies

MYR Group logo
MYR GroupMYRG
$68.62M-2.3%
Cabot Corporation logo
Cabot CorporationCBT
$32M+3,100%
Unifirst logo
UnifirstUNF
$35.22M-6.5%
Warrior Met Coal logo
Warrior Met CoalHCC
-$91.86M-59.5%
Travel + Leisure logo
Travel + LeisureTNL
$19M-81.0%
SSR Mining logo
SSR MiningSSRM
$175.66M+368%

Other financials

Income statement

See full
Operating income-$87.3M-22.3%
Net income-$83.0M-21.6%
EPS (diluted)-$2.46+90.9%

Balance sheet

See full
Cash & equivalents$161.2M-21.2%
Total debt$254.8M
Total equity$550.7M+186%
Total assets$850.8M

Cash flow

See full
Operating cash flow-$89.8M-64.7%
CapEx$262.0K-98.8%

Valuation

See full
Market cap$514.86M

Where this comes from

Calculated from Eikon Therapeutics, Inc. ’s reported figures.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eikon Therapeutics, Inc. 's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eikon Therapeutics, Inc. 's free cash flow?
Eikon Therapeutics, Inc. (EIKN) reported free cash flow of -$90.06M in Q1 2026.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.